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To the Editor: -We would like to thank Dr. Smolderen et al. for their interest in our article and are grateful for the opportunity to reply to their thoughtful comments. For our study, depression was defined as "new or persistent symptoms resulting in a recommendation for treatment" by the patient's primary care physician or mental health provider. 1 As part of a two-part protocol, the General Health Questionnaire was used as a screening tool for depression. However, depression was only diagnosed after the second step in the protocol-a careful evaluation by each patient's health provider. For our study, we relied on the treatment recommendations of the patients' physicians (and not the results of the screening tool) to identify those with depression. For this reason, we do not believe that we have overestimated the prevalence of depression for our patient population with symptomatic peripheral arterial disease (PAD). Smolderen et al. correctly note that the type of antidepressant therapy may have influenced the adverse cardiovascular outcomes for patients with depression. As we stated in our manuscript, "because of the small numbers of patients (in the study), subgroup analysis based upon the type of antidepressant medication...was not possible." 1 Further research is needed to better understand the impact of choice of antidepressant therapy on outcomes for patients with symptomatic PAD. Finally, PAD patients with critical limb ischemia have worse long-term outcomes when compared to claudicants. 2 As noted by Smolderen et al., lower ankle-brachial index (ABI) is also associated with increased risk for cardiovascular events. However, the ABI may be falsely elevated in patients with medial arterial calcification (MAC), a condition common in patient populations such as ours with prevalent diabetes and renal dysfunction. 3, 4 Furthermore, MAC is associated with worse outcomes for patients with PAD, and the prevalence of tibial artery calcification rises with increasing severity of lower limb ischemia. 5 In our patient population, previous data analyses have not demonstrated an association between lowest ABI and cardiovascular morbidity/ mortality, a finding that we attribute to the high prevalence of diabetes, renal dysfunction, and MAC. Therefore, we used the clinical marker of disease severity in the statistical analyses.
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